119 related articles for article (PubMed ID: 3774417)
1. Multiple sclerosis in 3 gipsy and 2 partly gipsy subjects (a clinical and immunogenetic study).
Pálffy G; Gyódi E; Petrányi G
Acta Med Hung; 1986; 43(1):31-7. PubMed ID: 3774417
[TBL] [Abstract][Full Text] [Related]
2. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis.
Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M
Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048
[TBL] [Abstract][Full Text] [Related]
3. [Disseminated sclerosis. Possible correlation between clinical forms and HLA groups (author's transl)].
Madigand M; Fauchet R; Oger J; Sabouraud O
Nouv Presse Med; 1981 Jun; 10(28):2349-52. PubMed ID: 7267340
[TBL] [Abstract][Full Text] [Related]
4. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
[TBL] [Abstract][Full Text] [Related]
5. HLA antigens in multiple sclerosis in Alsace.
Rumbach L; Tongio MM; Warter JM; Marescaux C; Grange D; Mayer S; Collard M
Biomed Pharmacother; 1985; 39(7):385-9. PubMed ID: 3830266
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis in Gypsies from southern Spain: prevalence, mitochondrial DNA haplogroups and HLA class II association.
Fernández O; Fernández V; Martinez-Cabrera V; Mayorga C; Alonso A; León A; Arnal C; Hens M; Luque G; de Ramón E; Caballero A; Leyva L
Tissue Antigens; 2008 May; 71(5):426-33. PubMed ID: 18312478
[TBL] [Abstract][Full Text] [Related]
7. [Immunogenetics of multiple sclerosis].
Clanet M; Cambon-Thomsen A; Rascol A
Pathol Biol (Paris); 1987 Mar; 35(3):299-302. PubMed ID: 3295695
[TBL] [Abstract][Full Text] [Related]
8. The HLA antigen distribution in the Gipsy population in Hungary.
Gyódi E; Tauszik T; Petranyi G; Kotvász A; Pálffy G; Takács I; Nemák P; Hollán SR
Tissue Antigens; 1981 Jul; 18(1):1-12. PubMed ID: 7330847
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis.
Callander M; Haghighi S; Landtblom AM; Ahlgren CE; Nilsson SI; Rydberg L; Al Khoury H; Rosegren L; Andersen O
Mult Scler; 2007 May; 13(4):441-5. PubMed ID: 17463066
[TBL] [Abstract][Full Text] [Related]
10. Sclerosis multiplex in gypsies.
Kálmán B; Takács K; Gyódi E; Kramer J; Füst G; Tauszik T; Guseo A; Kuntár L; Komoly S; Nagy C
Acta Neurol Scand; 1991 Sep; 84(3):181-5. PubMed ID: 1683089
[TBL] [Abstract][Full Text] [Related]
11. [Complement markers Bf and C4 in multiple sclerosis].
Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
[TBL] [Abstract][Full Text] [Related]
12. Association of HLA and multiple sclerosis.
Martin R; Vogt AB; Kropshofer H; Lichtenfels R
Behring Inst Mitt; 1994 Jul; (94):158-70. PubMed ID: 7998908
[TBL] [Abstract][Full Text] [Related]
13. [Distribution of histocompatibility antigens among multiple sclerosis patients in the Armenian population].
Darbinian VZh; Nersisian VM; Martirosian IG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(7):1038-43. PubMed ID: 6457477
[No Abstract] [Full Text] [Related]
14. [HLA-DRW antigens and multiple sclerosis].
De Moerloose PH; Jeannet M; Martins-da-Silva B; Werner-Favre C; Rohr J; Gauthier G
Schweiz Arch Neurol Neurochir Psychiatr; 1978; 123(1):51-61. PubMed ID: 83671
[TBL] [Abstract][Full Text] [Related]
15. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility.
Fernandez-Morera JL; Rodriguez-Rodero S; Tunon A; Martinez-Borra J; Vidal-Castineira JR; Lopez-Vazquez A; Rodrigo L; Rodrigo P; González S; Lahoz CH; Lopez-Larrea C
Tissue Antigens; 2008 Jul; 72(1):54-9. PubMed ID: 18588574
[TBL] [Abstract][Full Text] [Related]
16. Genetic predisposition to multiple sclerosis as revealed by immunoprinting.
Epplen C; Jäckel S; Santos EJ; D'Souza M; Poehlau D; Dotzauer B; Sindern E; Haupts M; Rüde KP; Weber F; Stöver J; Poser S; Gehler W; Malin JP; Przuntek H; Epplen JT
Ann Neurol; 1997 Mar; 41(3):341-52. PubMed ID: 9066355
[TBL] [Abstract][Full Text] [Related]
17. Association between HLA B7, DR2 and dysfunction of natural- and antibody-mediated cytotoxicity without connection with the deficient interferon production in multiple sclerosis.
Gyódi E; Benczur M; Pálffy G; Tálas M; Petrányi G; Földes I; Hollán SR
Hum Immunol; 1982 Jun; 4(3):209-17. PubMed ID: 6181031
[TBL] [Abstract][Full Text] [Related]
18. The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds.
Idiman E; Ozakbas S; Dogan Y; Kosehasanogullari G
J Neuroimmunol; 2009 Jul; 212(1-2):121-4. PubMed ID: 19457560
[TBL] [Abstract][Full Text] [Related]
19. Clinical behavior of multiple sclerosis is modulated by the MHC class I-chain-related gene A.
Fdez-Morera JL; Tunon A; Rodriguez-Rodero S; Rodrigo L; Martinez-Borra J; Gonzalez S; Lopez-Vazquez A; Lahoz CH; Lopez-Larrea C
Tissue Antigens; 2006 May; 67(5):409-14. PubMed ID: 16671949
[TBL] [Abstract][Full Text] [Related]
20. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
